Company Overview of Koronis Pharmaceuticals, Inc.
Koronis Pharmaceuticals, Inc., a biotechnology company, develops antiviral therapeutics based on Viral Decay Acceleration mechanism. It develops KP-1461 for AIDS/human immunodeficiency virus; and products for the treatment of hepatitis C and RSV. The company was founded in 1998 and is based in Seattle, Washington.
800 Fifth Avenue
Seattle, WA 98104
Founded in 1998
Key Executives for Koronis Pharmaceuticals, Inc.
Koronis Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|AVM Licensing Corp.||United States|
|Barrier Therapeutics, Inc.||United States|
|Cambridge Biomedical Inc.||United States|
|Amgen USA Inc.||United States|
|Tolera Therapeutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Milwaukee, WI | Robert W. BairdPosted: Apr 19
- Efland, NC | Orange County SchoolsPosted: May 19
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
- New Haven, CT | PeoplefirmPosted: Apr 04
Sponsored Financial Commentaries
To contact Koronis Pharmaceuticals, Inc., please visit www.koronispharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.